BCAX Earnings Bicara Therapeutics Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–11 of 11
| Q1 2026 | 2026-03-31 | -0.93 | 2026-05-11 | 10-Q |
| FY 2025 | 2025-12-31 | -2.52 | 2026-03-30 | 10-K |
| Q3 2025 | 2025-09-30 | -1.84 | 2025-11-10 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.18 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.68 | 2026-05-11 | 10-Q |
| FY 2025 | 2024-12-31 | -4.05 | 2026-03-30 | 10-K |
| Q3 2025 | 2024-09-30 | -11.27 | 2025-11-10 | 10-Q |
| Q2 2025 | 2024-06-30 | -38.19 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -18.94 | 2025-05-13 | 10-Q |
| FY 2024 | 2023-12-31 | -89.61 | 2025-03-27 | 10-K |
| Q3 2024 | 2023-09-30 | -70.18 | 2024-11-12 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.